Cargando…

PPAR Regulation of Inflammatory Signaling in CNS Diseases

Central nervous system (CNS) is an immune privileged site, nevertheless inflammation associates with many CNS diseases. Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear hormone receptors that regulate immune and inflammatory responses. Specific ligands for PPARα, γ, and δ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bright, John J., Kanakasabai, Saravanan, Chearwae, Wanida, Chakraborty, Sharmistha
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2490815/ https://www.ncbi.nlm.nih.gov/pubmed/18670616 http://dx.doi.org/10.1155/2008/658520

Ejemplares similares

PPARγ Agonists Promote Oligodendrocyte Differentiation of Neural Stem Cells by Modulating Stemness and Differentiation Genes
por: Kanakasabai, Saravanan, et al.
Publicado: (2012)

PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells
por: Pestereva, E, et al.
Publicado: (2012)

PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells
por: Chearwae, W, et al.
Publicado: (2008)

Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells
por: Chakraborty, S, et al.
Publicado: (2011)

PPAR agonists as therapeutics for CNS trauma and neurological diseases
por: Mandrekar-Colucci, Shweta, et al.
Publicado: (2013)

A role for CNS PPARγ in the regulation of energy balance
por: Ryan, Karen K., et al.
Publicado: (2011)

Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway
por: Ai, Ruo-Song, et al.
Publicado: (2022)

Aptamers as a Sensitive Tool to Detect Subtle Modifications in Therapeutic Proteins
por: Zichel, Ran, et al.
Publicado: (2012)

Kynurenines in CNS disease: regulation by inflammatory cytokines
por: Campbell, Brian M., et al.
Publicado: (2014)

PPARγ in Inflammatory Bowel Disease
por: Annese, Vito, et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors
por: Tatenhorst, Lars, et al.
Publicado: (2008)

The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
por: Kinzel, Silke, et al.
Publicado: (2017)

Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
por: Spiteri, Alanna G., et al.
Publicado: (2021)

The Effects of Hypoxia and Inflammation on Synaptic Signaling in the CNS
por: Mukandala, Gatambwa, et al.
Publicado: (2016)

Hedgehog Signaling in CNS Remyelination
por: Fang, Minxi, et al.
Publicado: (2022)

Microglia: Agents of the CNS Pro-Inflammatory Response
por: Rodríguez-Gómez, José A., et al.
Publicado: (2020)

Lysophospholipid-Related Diseases and PPARγ Signaling Pathway
por: Tsukahara, Tamotsu, et al.
Publicado: (2017)

The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation
por: Iannotti, Fabio Arturo, et al.
Publicado: (2021)

Cofilin Signaling in the CNS Physiology and Neurodegeneration
por: Namme, Jannatun Nayem, et al.
Publicado: (2021)

Astrocyte Regulation of CNS Inflammation and Remyelination
por: Claycomb, Kumiko I., et al.
Publicado: (2013)

Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases
por: Kapaki, Elisabeth, et al.
Publicado: (2022)

Integrin Signaling in Oligodendrocytes and Its Importance in CNS Myelination
por: O'Meara, Ryan W., et al.
Publicado: (2011)

PPARs in Rhythmic Metabolic Regulation and Implications in Health and Disease
por: Charoensuksai, Purin, et al.
Publicado: (2010)

Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS
por: Illes, Peter, et al.
Publicado: (2020)

PPARδ repression in Huntington’s disease and its essential role in CNS translate into a potent agonist therapy
por: Dickey, Audrey S., et al.
Publicado: (2015)

PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
por: Wang, Yaping, et al.
Publicado: (2020)

CNS Diseases and Uveitis
por: Allegri, Pia, et al.
Publicado: (2011)

Hexarelin Signaling to PPAR [Formula: see text] in Metabolic Diseases
por: Demers, Annie, et al.
Publicado: (2008)

Regulation of Bile Acid and Cholesterol Metabolism by PPARs
por: Li, Tiangang, et al.
Publicado: (2009)

Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer's Disease
por: Govindarajulu, Manoj, et al.
Publicado: (2018)

PPAR Signaling in Placental Development and Function
por: Barak, Yaacov, et al.
Publicado: (2008)

PPARs Signaling and Cancer in the Gastrointestinal System
por: Pazienza, Valerio, et al.
Publicado: (2012)

The role of JAK-STAT signaling within the CNS
por: Nicolas, Celine S., et al.
Publicado: (2013)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Gut–CNS-Axis as Possibility to Modulate Inflammatory Disease Activity—Implications for Multiple Sclerosis
por: Fleck, Ann-Katrin, et al.
Publicado: (2017)

Electroacupuncture Reduces Weight Gain Induced by Rosiglitazone through PPARγ and Leptin Receptor in CNS
por: Jing, Xinyue, et al.
Publicado: (2016)

PPARs in Alzheimer's Disease
por: Kummer, Markus P., et al.
Publicado: (2008)

PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs
por: Peyrou, Marion, et al.
Publicado: (2012)

MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers
por: Portius, Dorothea, et al.
Publicado: (2017)

NF-κB signaling regulates myelination in the CNS
por: Blank, Thomas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mnulvp7ti8a5lubbkpj57mmvt4